New Joint Action to Reduce the Burden of Cardiovascular Disease and Diabetes

European CommissionNon-communicable diseases such as cardiovascular diseases and diabetes pose significant health challenges and are amongst the leading causes of mortality in the EU. A new Joint Action on CARdiovascular diseases and DIabetes in Europe (JACARDI), funded by the EU4Health programme with an unprecedented EUR 53 million, kicked off this week to support 21 countries to reduce the burden of these two non-communicable diseases (NCDs).

The initiative is set to deploy 142 pilot projects across Europe, covering the entire patient journey: from improving health literacy and awareness, enhancing screening and primary prevention among high-risk populations, reaching out to people living with cardiovascular diseases and diabetes as well as their care providers and improving service pathways, self-management and labour participation. JACARDI will also address transversal and intersectional aspects, e.g., promoting equity in health, social, cultural, and ethnic diversity, and the improvement of data availability.

Background information

Around two-thirds of premature deaths in the World Health Organization European Region – are caused by four major NCDs: cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. Behavioural and biological risk factors are at the root of 85% of this burden. With the Healthier Together – EU non-communicable diseases initiative, the Commission recognises the importance of a comprehensive, strategic approach to preventing NCDs.

Useful links:

Most Popular Now

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...